Study Name:
Hydroxychloroquine in pediatric ILD START randomized controlled in parallel-group, then switch placebo to active drug, and STOP randomized controlled in parallel-group to evaluate the efficacy and safety of hydroxychloroquine (HCQ) (E-Rare3 study)

Phase:
Phase 2a Clinical Trial

EudraCT number:
2013-003714-40

National Principal Investigator:
Prof. Dr. Teresa Bandeira

Participating Countries:
Austria, Italy, Poland, Portugal, Spain, Turkey

Sites in Portugal:
Centro Hospitalar Lisboa Norte - Hospital de Santa Maria

Sponsor:
Klinikum der Universität München

Status:
Submission phase